This book evolved from several courses in combinatorics and graph theory given at Appalachian State University and UCLA. Chapter 1 focuses on finite graph theory, including trees, planarity, coloring, matchings, and Ramsey theory. Chapter 2 studies combinatorics, including the principle of inclusion and exclusion, generating functions, recurrence relations, Pólya theory, the stable marriage problem, and several important classes of numbers. Chapter 3 presents infinite pigeonhole principles, König's lemma, and Ramsey's theorem, and discusses their connections to axiomatic set theory. The text is written in an enthusiastic and lively style. It includes results and problems that cross subdisciplines, emphasizing relationships between different areas of mathematics. In addition, recent results appear in the text, illustrating the fact that mathematics is a living discipline. The text is primarily directed toward upper-division undergraduate students, but lower-division undergraduates with a penchant for proof and graduate students seeking an introduction to these subjects will also find much of interest.
These notes were first used in an introductory course team taught by the authors at Appalachian State University to advanced undergraduates and beginning graduates. The text was written with four pedagogical goals in mind: offer a variety of topics in one course, get to the main themes and tools as efficiently as possible, show the relationships between the different topics, and include recent results to convince students that mathematics is a living discipline.
Volume 1 of this series presents five cases on trade negotiations that have had important effects on trade policy rulemaking, and an analytic framework for evaluating these negotiations."--BOOK JACKET.
With the pervasiveness of the information revolution, the preservation of intellectual property rights through patents, copyrights, and trademarks has become far more difficult. In this book, Michael Ryan explains the issues, politics, and diplomacy of balancing intellectual property rights with the public's right of access.
This comprehensive, detailed reference provides readers with both a working knowledge of Mathematica in general and a detailed knowledge of the key aspects needed to create the fastest, shortest, and most elegant implementations possible. It gives users a deeper understanding of Mathematica by instructive implementations, explanations, and examples from a range of disciplines at varying levels of complexity. The three volumes -- Programming, Graphics, and Mathematics, total 3,000 pages and contain more than 15,000 Mathematica inputs, over 1,500 graphics, 4,000+ references, and more than 500 exercises. This first volume begins with the structure of Mathematica expressions, the syntax of Mathematica, its programming, graphic, numeric and symbolic capabilities. It then covers the hierarchical construction of objects out of symbolic expressions, the definition of functions, the recognition of patterns and their efficient application, program flows and program structuring, and the manipulation of lists. An indispensible resource for students, researchers and professionals in mathematics, the sciences, and engineering.
In todayand’s fast-paced and ultra-competitive high-tech environment, an effectively managed patent licensing program is a must. The Second Editio n of Drafting Technology Patent License Agreements shows you how to achieve one. This valuable resource covers all of the legal and business transactional issues you are likely to encounter during the drafting and negotiation of patent licensing agreements. It guides you step-by-step through the unique aspects of the implementation of a patent licensing program for computers, electronics, telecommunications, and other industries, and it clarifies the issues involved in the enforcement and litigation of these patents. Youand’ll find incisive legal analysis on complex issues including: How to implement an aggressive and well-managed patent licensing program How to evaluate a patent or portfolio for licensing How to identify industry segments and select potential licensees How to discuss terms with industry targets How to formulate an effective licensing strategy How to use databases effectively in patent practice How to organize a licensing team How to file a patent infringement lawsuit And many more critical issues like these. Included with this key resource are 40 time-saving forms on the bonus CD-ROM: Forms for establishing a new technology company using patented technology Confidentiality agreements (for a third-party vendor, third party evaluation, or consultant) A projected royalty stream analysis A semiconductor technology cross-licensing agreement Software technology license agreements Model licensing and patent agreements for the telecommunications industry And many more!
Searching for Magic Bullets reveals the quest of consumers, health professionals, and drug developers to find safer and faster methods of bringing new medications to the marketplace. Authors Basara and Montagne explore the current drug development and approval processes, their strengths and weaknesses, and the mechanisms by which patients and organizations evade these processes. Readers learn about the fundamentals of traditional and nontraditional drug discovery and development as they occur in the U.S., as well as the views of consumers, patients, and health professionals. Specific case studies of non-traditional drug development and acquisition strategies are highlighted, including AIDS medications, orphan drugs, and patient importation of medications. Basara and Montagne establish the differences in both knowledge and opinions of health consumers and health professionals regarding drug development, as well as how these differences often lead to frustration, dissatisfaction, and misappropriation of resources. The authors pinpoint the need for consumers and patients to know much more about the discovery and development of medicines, and for health professionals and students to understand patients’concerns, needs and beliefs, including their reasons for considering alternative methods of drug development and acquisition. Searching for Magic Bullets is a springboard from which consumers, health professionals, and students can discuss, debate, and resolve these issues and begin to develop more capable drug development and approval systems. This groundbreaking new book enlightens health professionals about patients’views regarding medication discovery and development and informs consumers and patients about the sometimes conflicting views of health professionals. It is divided into three sections: drug development and approval in the U.S., a case study of orphan drugs, and risky and sometimes illegal ways in which consumers evade the traditional drug development and approval systems. An Overview of the Chapters: A Review of the Drug Development Process of the Pharmaceutical Industry: Presents the steps that must be taken when researching and developing a new medication. The Food and Drug Administration and the Drug Approval Process: Describes the history and scope of the FDA, the steps involved in acquiring drug approval, and the various stages of clinical testing. Orphan Drug Legislation: A review of the Orphan Drug Act of 1983 and the changes that have recently been proposed by Congress. The impact of the Act is highlighted through a description of products that have been made available since the legislation was enacted. Issues of controversy are also highlighted. Non-traditional Methods of Drug Development: The role of patients and consumers in drug development and evaluation is discussed, with an emphasis on the perceived shortcomings of the formal system. Patient Influence on Drug Development and Regulation: The influence of patient advocacy groups and consumers is discussed in relation to the development and approval of orphan drugs, the fast-tracking of specific medications, and the use of unapproved and alternative therapies. Prescription Drug Importation: Clarifies the current drug importation regulations, as well as provides specific directions for patients wishing to receive such products or learn more about FDA importation laws. The final chapter summarizes safe and rational techniques that empower consumers in their search for beneficial drug therapies. Resources and strategies for obtaining and using information are provided as a reference for readers. A glossary of terms, acronyms, and a directory of supplemental information sources strengthens the reader's understanding of the information presented. Who Benefits From This Book? Consumers and patients can use Searching for Magic Bullets as an accurate source of information about significant but often confusing medical issues. The FDA and the way medications are developed are easily misunderstood, while alternative therapies and medication sources are often believed to be the only options. Patients will learn the viewpoints of the pharmaceutical industry, the government, and their health care professionals; the rationale for various steps in the drug development process; the risks and benefits of participation in clinical trials; how to obtain the highest quality care, make informed health decisions, and reduce health care costs; and finally, how to cope with a rare disease and/or limited access to approved medications. The result is an informed, influential, and active patient. For health professionals, this book reviews the steps of drug development and approval and provides explanations for drug development decisions; drug approval time lag; and patient frustrations, misinterpretations, and expectations. It is critical for health professionals to understand the needs of patients and to determine how they can work with patients to find acceptable solutions. The literature references and medical information sources are invaluable in this regard. Pharmaceutical industry executives, product managers, clinical researchers, and sales representatives will find a concise and timely examination of the ways in which medications are discovered, developed, marketed, and used by patients. Discussions of orphan drug development, biotechnology products, and patient issues may also provide new insights into these often misunderstood areas. Pharmacy, medical, nursing, and other students will find this book a consolidated reference source and guidebook for information about the primary issues surrounding drug development and the FDA approval process. Patients’knowledge of alternative medical therapies will only increase and health care curricula must include material that helps students understand patients’perceptions of the medication development and approval systems, as well as the importance of patients in health care decisionmaking. The disadvantages of current drug development and approval systems are described with the hope that future health professionals can amend these processes and ultimately enhance patient care.
The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.
Innovation For The 21st Century' contends that intellectual property and antitrust, the two most important laws fostering innovation, are not being used most effectively to achieve this goal and offers various proposals that individually and collectively remedy this deficiency.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.